Kotliar, Konstantin
Hauser, Christine
Ortner, Marion
Muggenthaler, Claudia
Diehl-Schmid, Janine
Angermann, Susanne
Hapfelmeier, Alexander
Schmaderer, Christoph
Grimmer, Timo
Article History
Received: 10 May 2017
Accepted: 21 September 2017
First Online: 10 October 2017
Competing Interests
: TG reported no competing interests with regards to the submitted work. Outside the submitted work: TG received consulting fees from Actelion, Eli Lilly, MSD; Novartis, Quintiles, Roche Pharma, lecture fees from Biogen, Lilly, Parexel, Roche Pharma, and grants to his institution from Actelion and PreDemTech. All other authors reported no biomedical financial interests or potential conflicts of interest.